| Plasma markers of disrupted gut permeability in severe COVID-19 patients LB Giron, H Dweep, X Yin, H Wang, M Damra, AR Goldman, N Gorman, ... Frontiers in Immunology 12, 686240, 2021 | 143 | 2021 |
| CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells M Abdel-Mohsen, L Kuri-Cervantes, J Grau-Exposito, AM Spivak, RA Nell, ... Science translational medicine 10 (437), eaar6759, 2018 | 129 | 2018 |
| Serotonin reduction in post-acute sequelae of viral infection AC Wong, AS Devason, IC Umana, TO Cox, L Dohnalová, L Litichevskiy, ... Cell 186 (22), 4851-4867. e20, 2023 | 78 | 2023 |
| COVID-19 severity is associated with differential antibody Fc-mediated innate immune functions OS Adeniji, LB Giron, M Purwar, NF Zilberstein, AJ Kulkarni, MW Shaikh, ... MBio 12 (2), 10.1128/mbio. 00281-21, 2021 | 59 | 2021 |
| Frontline science: plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy SK Vadrevu, I Trbojevic-Akmacic, AV Kossenkov, F Colomb, LB Giron, ... Journal of leukocyte biology 104 (3), 461-471, 2018 | 43 | 2018 |
| Glycosylation of Zika virus is important in host–virus interaction and pathogenic potential NK Routhu, SD Lehoux, EA Rouse, MRM Bidokhti, LB Giron, A Anzurez, ... International journal of molecular sciences 20 (20), 5206, 2019 | 42 | 2019 |
| Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial RS Diaz, IL Shytaj, LB Giron, B Obermaier, E della Libera Jr, J Galinskas, ... International journal of antimicrobial agents 54 (5), 592-600, 2019 | 39 | 2019 |
| Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling LB Giron, MJ Peluso, J Ding, G Kenny, NF Zilberstein, J Koshy, KY Hong, ... JCI insight 7 (15), 2022 | 38 | 2022 |
| Galectin-9 mediates HIV transcription by inducing TCR-dependent ERK signaling F Colomb, LB Giron, TA Premeaux, BI Mitchell, T Niki, E Papasavvas, ... Frontiers in immunology 10, 267, 2019 | 36 | 2019 |
| Severe COVID-19 is fueled by disrupted gut barrier integrity LB Giron, H Dweep, X Yin, H Wang, M Damra, AR Goldman, N Gorman, ... | 35 | 2020 |
| Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV LB Giron, CS Palmer, Q Liu, X Yin, E Papasavvas, R Sharaf, B Etemad, ... Nature Communications 12 (1), 3922, 2021 | 34 | 2021 |
| Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection LB Giron, CE Tanes, MH Schleimann, PA Engen, LM Mattei, A Anzurez, ... Mucosal immunology 13 (5), 753-766, 2020 | 31 | 2020 |
| Breaking the glyco-code of HIV persistence and immunopathogenesis F Colomb, LB Giron, I Trbojevic-Akmacic, G Lauc, M Abdel-Mohsen Current HIV/AIDS Reports 16, 151-168, 2019 | 28 | 2019 |
| TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes MH Schleimann, ML Kobberø, LK Vibholm, K Kjær, LB Giron, ... EBioMedicine 45, 328-340, 2019 | 27 | 2019 |
| Thalidomide is associated with increased t cell activation and inflammation in antiretroviral-naive HIV-infected individuals in a randomised clinical trial of efficacy and safety TRC Vergara, S Samer, JR Santos-Oliveira, LB Giron, MS Arif, ... EBioMedicine 23, 59-67, 2017 | 27 | 2017 |
| Development of Siglec-9 blocking antibody to enhance anti-tumor immunity H Choi, M Ho, OS Adeniji, L Giron, D Bordoloi, AJ Kulkarni, AP Puchalt, ... Frontiers in Oncology 11, 778989, 2021 | 24 | 2021 |
| Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint LB Giron, E Papasavvas, L Azzoni, X Yin, A Anzurez, M Damra, ... Aids 34 (5), 681-686, 2020 | 24 | 2020 |
| Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV T Ma, M McGregor, L Giron, G Xie, AF George, M Abdel-Mohsen, ... Elife 11, e78870, 2022 | 18 | 2022 |
| Abnormal food timing and predisposition to weight gain: Role of barrier dysfunction and microbiota F Bishehsari, PA Engen, D Adnan, S Sarrafi, S Wilber, M Shaikh, ... Translational Research 231, 113-123, 2021 | 18 | 2021 |
| Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294 S Samer, MS Arif, LB Giron, JPL Zukurov, J Hunter, BT Santillo, ... Brazilian Journal of Infectious Diseases 24, 150-159, 2020 | 16 | 2020 |
Ali KeshavarzianRush University Medical Center-Digestive DiseaseVerified email at Rush.edu
